Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3, limited to version metadata and not affecting study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A Scleroderma topic tag was added, and a link to the Genetic and Rare Diseases Information Center was added to Resources. These changes improve discoverability and provide an additional information source for patients without altering the study details.
    Difference
    0.1%
    Check dated 2026-02-18T16:39:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the Notice about funding lapse and operating status and the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T11:55:53.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operating status was added, with references to cc.nih.gov and opm.gov. The page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T10:39:51.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Page changes: the glossary toggle is now shown, and new metadata items appear including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:33:48.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added to the page; no substantive changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:38.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.